BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
BioXcel Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026
- Market cap
- $757.50K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
BioXcel Therapeutics has not reported a dividend
No dividend per share appears in BioXcel Therapeutics's annual filings since fiscal 2016.